New lab test could take the guesswork out of antibiotic choice for gum disease

NCT ID NCT03863249

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new lab method (xCELLigence system) to grow oral biofilms and select the most effective antibiotic for each patient with chronic periodontitis. 64 adults with severe gum disease received standard deep cleaning plus an antibiotic chosen by the new test. The goal was to see if this approach improves clinical outcomes like pocket depth and bleeding. The study is complete, but results are not yet reported.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
antibiotics (amoxicillin, metronidazole, azithromycin)
What this could lead to
If successful, this could lead to a faster, more accurate way to choose antibiotics for gum disease, potentially improving outcomes and reducing antibiotic resistance.
What could go wrong
This is a small, completed Phase 4 trial focused on developing a lab test, not testing a new treatment. The method may not prove better than current practice in larger, real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PERIODONTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alveolar Bone Loss chronic periodontitis Dental Plaque Dysbiosis periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Marta Reglero Santaolaya

    Valencia, Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.